bioRxiv Science⌕ Search

Biology subjects

Quarantani, G.

Publications and source records attributed to Quarantani, G..

2 recordsLinked to original sources

OpenSplice: the impact of half a million mutations on the alternative splicing of 600 human exons

Alternative splicing of mRNA precursors is an important step in gene regulation and a major mechanism by which genetic variants cause human disease. However, changes in splicing have only been quantified for a tiny fraction of possible variants in the human genome, limiting our ability to interpret clinical variants, evaluate and develop machine learning models, and understand the splicing regulatory code. Here, to address this data gap, we present OpenSplice, a well-calibrated experimental dataset that quantifies the impact of >590,000 variants on the splicing of >600 human alternatively spliced exons. OpenSplice increases the number of exons with site saturation mutagenesis data [~]28-fold, quantifying the impact of all possible exonic and proximal intronic single nucleotide (nt) substitutions, as well as all 1, 3, 6 and 21nt deletions. Hundreds of thousands of variants affect splicing and we use the data to evaluate machine learning models, to interpret clinical variants, and to map splicing regulatory architectures. Exons and introns exhibit a broad spectrum of regulatory landscapes, including configurations dominated by enhancers or silencers, checkerboard-like patterns with interleaved enhancers and silencers, and sparse architectures with minimal regulatory content. Silencers are particularly important for determining inclusion levels. OpenSplice provides a complete atlas of variants that impact splicing, a rich testing and training dataset for machine learning models, and a comprehensive map of regulatory elements for mechanistic studies.

genomics↗

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

Altered splicing is a frequent mechanism by which genetic variants cause disease and antisense oligonucleotides (AONs) that target pre-mRNA splicing have been approved as therapeutics for multiple pathologies including patient-customized treatments for rare diseases. However, the regulatory architecture of human exons remains poorly understood and AON discovery is currently slow and expensive, limiting the wider adoption of the approach. Here we show that that systematic deletion scans -which can be made experimentally at very low cost - provide an efficient strategy to chart the regulatory landscape of human exons and to rapidly identify effective splicing-modulating oligonucleotides in a fully quantitative manner. Our results suggest a mechanism for the evolutionary origins of unusually short microexons and the repression of transmembrane domain-encoding exons, and reveal a checkerboard architecture of sequential enhancers and silencers in a model alternative exon. Accurate prediction of the effects of deletions using deep learning provides a resource, DANGO, that maps the splicing regulatory landscape of all human exons and predicts effective splicing-altering antisense oligonucleotides genome-wide.

genetics↗